Hypersensitivity reactions to non-vitamin K oral anticoagulants - a review of literature and diagnostic work-up proposal

被引:15
作者
Carli, G. [1 ]
Farsi, A. [1 ]
Chiarini, F. [1 ]
Lippolis, D. [2 ]
Cortellini, G. [2 ]
机构
[1] Azienda USL Toscana Centro, SOS Allergol & Immunol, Pistoia, Italy
[2] Osped Infermi, UOC Med Interna & Reumatol, Allergol, Rimini, Italy
关键词
novel oral anticoagulants or non-vitamin K oral anticoagulants (NOACs); rivaroxaban; apixaban; edoxaban; dabigatran; hypersensitivity; LEUKOCYTOCLASTIC VASCULITIS; DABIGATRAN; THROMBOCYTOPENIA; SKIN;
D O I
10.23822/EurAnnACI.1764-1489.80
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Non-vitamin K antagonist oral anticoagulants (NOACs) are increasingly being used in hospital and outpatient settings as safe alternatives to warfarin. Hypersensitivity reactions have been described for NOACs and can be classified according to Gell and Coombs. We reviewed case reports of possible drug hypersensitivity reactions, noticing a predominance of delayed reactions (both mild and severe) and the absence of cross-reactions to warfarin and low molecular weight heparins. International experience on diagnostic tests is lacking. The vast majority of authors refer to probability scores and rely on biopsy to classify vasculitis and rule out differential diagnoses. We propose to adapt available tests to confirm the patient's reactivity to new anticoagulants. Among in vivo tests, patch testing revealed promising in delayed reactions.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 39 条
  • [31] Rivaroxaban-induced serum sickness after total knee arthroplasty
    Snyder, David J.
    Matusik, F. Bahar
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (18) : 1567 - 1571
  • [32] Drug Allergy: An Updated Practice Parameter
    Solensky, Roland
    Khan, David A.
    Bernstein, I. Leonard
    Bloomberg, Gordon R.
    Castells, Mariana C.
    Mendelson, Louis M.
    Weiss, Michael E.
    Bernstein, David I.
    Blessing-Moore, Joann
    Cox, Linda
    Lang, David M.
    Nicklas, Richard A.
    Oppenheimer, John
    Portnoy, Jay M.
    Randolph, Christopher
    Schuller, Diane E.
    Spector, Sheldon L.
    Tilles, Stephen
    Wallace, Dana
    Dowling, Paul J.
    Dykewicz, Mark
    Greenberger, Paul A.
    Macy, Eric M.
    May, Kathleen R.
    Nguyen, Myngoc T.
    Schwartz, Lawrence B.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 105 (04) : 259 - +
  • [33] Rash Associated with Dabigatran Etexilate
    To, Kim
    Reynolds, Carl
    Spinler, Sarah A.
    [J]. PHARMACOTHERAPY, 2013, 33 (03): : e23 - e27
  • [34] Iron complex, dabigatran and toxic epidermal necrolysis syndrome: a case-report
    Tsoumpris, A.
    Tzimas, T.
    Gkabrelas, K.
    Akritidis, N.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (02) : 177 - 178
  • [35] NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands
    van den Heuvel, J. M.
    Hovels, A. M.
    Buller, H. R.
    Mantel-Teeuwisse, A. K.
    de Boer, A.
    Maitland-van der Zee, A. H.
    [J]. THROMBOSIS JOURNAL, 2018, 16
  • [36] A rare side effect seen due to the use of apixaban: Palmoplantar psoriasiform drug eruption
    Veliyev, Vusal
    Ozmen, Ibrahim
    Yasar, Salim
    Gursoy, Erol
    Koklu, Mustafa
    Celik, Murat
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (03) : 213 - 215
  • [37] Hypersensitivity reaction after administration of rivaroxaban (Xarelto)
    Vernon, Hampton M.
    Nielsen, Andrew K.
    O'Bryan, Edward C.
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (07) : 1325.e1 - 1325.e2
  • [38] Winkle, 2012, DABIGATRAN ABLATION, V23
  • [39] A case report describing a suspected rivaroxaban hypersensitivity reaction in a surgical patient
    Yates, J.
    Choudhry, M.
    Keys, G.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (02) : 159 - 161